Correlation Between Eiger Biopharmaceutica and Reviva Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Eiger Biopharmaceutica and Reviva Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eiger Biopharmaceutica and Reviva Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Eiger Biopharmaceuticals and Reviva Pharmaceuticals Holdings, you can compare the effects of market volatilities on Eiger Biopharmaceutica and Reviva Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eiger Biopharmaceutica with a short position of Reviva Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eiger Biopharmaceutica and Reviva Pharmaceuticals.

Diversification Opportunities for Eiger Biopharmaceutica and Reviva Pharmaceuticals

0.51

Correlation Coefficient

Eiger Biopharmaceutica  Reviva Pharmaceuticals

Very weak diversification

The 3 months correlation between Eiger and Reviva is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Eiger Biopharmaceuticals and Reviva Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reviva Pharmaceuticals and Eiger Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eiger Biopharmaceuticals are associated (or correlated) with Reviva Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reviva Pharmaceuticals has no effect on the direction of Eiger Biopharmaceutica i.e., Eiger Biopharmaceutica and Reviva Pharmaceuticals go up and down completely randomly.

Pair Corralation between Eiger Biopharmaceutica and Reviva Pharmaceuticals

If you would invest  124.00  in Reviva Pharmaceuticals Holdings on September 3, 2024 and sell it today you would lose (4.00) from holding Reviva Pharmaceuticals Holdings or give up 3.23% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	1.56%
Values	Daily Returns

Eiger Biopharmaceuticals  vs.  Reviva Pharmaceuticals Holding

Eiger Biopharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Eiger Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable technical and fundamental indicators, Eiger Biopharmaceutica is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.

Reviva Pharmaceuticals

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Reviva Pharmaceuticals Holdings are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Reviva Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Eiger Biopharmaceutica and Reviva Pharmaceuticals

The main advantage of trading using opposite Eiger Biopharmaceutica and Reviva Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eiger Biopharmaceutica position performs unexpectedly, Reviva Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reviva Pharmaceuticals will offset losses from the drop in Reviva Pharmaceuticals' long position.

The idea behind Eiger Biopharmaceuticals and Reviva Pharmaceuticals Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.